APA (7th ed.) Citation

Russell, N., Wilhelm-Benartzi, C., Knapper, S., Batten, L., Canham, J., Hinson, E., . . . Dennis, M. (2022, June). S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL. HemaSphere.

Chicago Style (17th ed.) Citation

Russell, N., et al. "S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL." HemaSphere Jun. 2022.

MLA (9th ed.) Citation

Russell, N., et al. "S128: A RANDOMISED COMPARISON OF CPX-351 AND FLAG-IDA IN HIGH RISK ACUTE MYELOID LEUKAEMIA. RESULTS FROM THE NCRI AML19 TRIAL." HemaSphere, Jun. 2022.